SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-23-001112
Filing Date
2023-08-07
Accepted
2023-08-07 16:23:22
Documents
15
Period of Report
2023-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618839_8k-arct.htm   iXBRL 8-K 30190
2 e618839_ex1-1.htm EX-1.1 22242
3 e618839_ex99-1.htm EX-99.1 72036
7 GRAPHIC image_001.jpg GRAPHIC 113761
  Complete submission text file 0001193805-23-001112.txt   475700

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE arct-20230807.xsd EX-101.SCH 2965
5 XBRL LABEL FILE arct-20230807_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE arct-20230807_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT e618839_8k-arct_htm.xml XML 3746
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 231147932
SIC: 2834 Pharmaceutical Preparations